Literature DB >> 6588342

Albright's syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Report of a case.

M B Hall, A G Sclar, D F Gardner.   

Abstract

To our knowledge, this is the only reported case of Albright's syndrome with reactivation of the fibrous dysplasia in adulthood, a marked elevation of growth hormone secondary to a pituitary adenoma, and development of osteosarcoma within the reactivated fibrous dysplasia. In addition, this patient also had hyperthyroidism with normal TSH levels, indicating the presence of two separate endocrinopathies. Reactivation of the fibrous dysplasia after years of arrested growth in this patient is good evidence that fibrous dysplasia does not "burn out" after adolescence but that growth ceases only when growth hormone declines to adult levels.

Entities:  

Mesh:

Year:  1984        PMID: 6588342     DOI: 10.1016/0030-4220(84)90282-2

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  7 in total

1.  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Authors:  S I Sherman; P W Ladenson
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

2.  Osteosarcoma of the Skull Base after Radiation Therapy in a Patient with McCune-Albright Syndrome: Case Report.

Authors:  Marlan R Hansen; J Craig Moffat
Journal:  Skull Base       Date:  2003-05

Review 3.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

Review 4.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

5.  [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].

Authors:  J Pfeilschifter; R Ziegler
Journal:  Med Klin (Munich)       Date:  1998-06-15

6.  Osteosarcoma associated with diamond-blackfan anaemia: a case of a child receiving growth hormone therapy.

Authors:  Robert S Lee; Deborah Higgs; Omar Haddo; Jean Pringle; Timothy W R Briggs
Journal:  Sarcoma       Date:  2004

Review 7.  Fibrous Dysplasia/McCune-Albright Syndrome: A Rare, Mosaic Disease of Gα s Activation.

Authors:  Alison M Boyce; Michael T Collins
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.